News
Axios on MSN4d
Why GLP-1s could become the "everything drug"
The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Opening Minds through Art (OMA) is an award-winning, evidence-based program. It’s an opportunity for creative self-expression ...
Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.
Health and Me on MSN5d
Weight Loss Drugs For Dementia – Study Finds It May Prevent Cognitive As Well As Cardiovascular Issues
As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback